[Treatment of atopic dermatitis: practical approach]

G Rossetti1, E Laffitte, P A Eigenmann

  • 1dr.rossetti@bluewin.ch

Revue Medicale Suisse
|March 26, 2005
PubMed

Insights

Atopic dermatitis (AD) management involves moisturizing, topical treatments, and addressing potential food allergies. New immuno-modulatory macrolides offer alternatives to steroids, but long-term effects require further study.

Area of Science:

  • Dermatology
  • Pediatrics
  • Allergology

Context:

  • Atopic dermatitis (AD) is a prevalent chronic skin condition in children.
  • Current AD treatment includes moisturizing, parental education, topical anti-infectives, and topical steroids.
  • The long-term effects of newer immuno-modulatory macrolides (tacrolimus, pimecrolimus) are not yet fully understood.

Purpose:

  • To outline current management strategies for atopic dermatitis.
  • To introduce immuno-modulatory macrolides as an alternative to topical steroids.
  • To highlight the role of food allergies and the atopy march in AD.

Summary:

  • Atopic dermatitis (AD) management focuses on skin hydration, infection control, and topical therapies.
  • Immuno-modulatory macrolides are emerging as alternatives to topical steroids, though long-term safety data is pending.
  • Identifying and confirming food allergies is crucial before dietary elimination, and physicians should anticipate potential respiratory symptoms due to the atopy march.

Impact:

  • Provides a concise overview of current atopic dermatitis treatment approaches.
  • Informs clinicians about novel therapeutic options and their current limitations.
  • Emphasizes the importance of a holistic approach to managing AD, considering allergies and the broader atopic spectrum.

Related Concept Videos

Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...